These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 31637852)

  • 1. RNA-Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators.
    Guan C; Chernyak N; Dominguez D; Cole L; Zhang B; Mirkin CA
    Small; 2019 Oct; 15(43):e1903338. PubMed ID: 31637852
    [No Abstract]   [Full Text] [Related]  

  • 2. High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation.
    Gadd AJR; Castelletto V; Kabova E; Shankland K; Perrie Y; Hamley I; Cobb AJA; Greco F; Edwards AD
    Eur J Pharm Sci; 2018 Oct; 123():268-276. PubMed ID: 30048801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.
    Hornung V; Guenthner-Biller M; Bourquin C; Ablasser A; Schlee M; Uematsu S; Noronha A; Manoharan M; Akira S; de Fougerolles A; Endres S; Hartmann G
    Nat Med; 2005 Mar; 11(3):263-70. PubMed ID: 15723075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Inhibitory Activity of Oligonucleotides on TLR7 Sensing.
    Ferrand J; Gantier MP
    Methods Mol Biol; 2016; 1390():79-90. PubMed ID: 26803623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA recognition via TLR7 and TLR8.
    Hornung V; Barchet W; Schlee M; Hartmann G
    Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory spherical nucleic acids.
    Radovic-Moreno AF; Chernyak N; Mader CC; Nallagatla S; Kang RS; Hao L; Walker DA; Halo TL; Merkel TJ; Rische CH; Anantatmula S; Burkhart M; Mirkin CA; Gryaznov SM
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3892-7. PubMed ID: 25775582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of immunostimulatory RNA oligonucleotides by gelatin nanoparticles triggers an efficient antitumoral response.
    Bourquin C; Wurzenberger C; Heidegger S; Fuchs S; Anz D; Weigel S; Sandholzer N; Winter G; Coester C; Endres S
    J Immunother; 2010; 33(9):935-44. PubMed ID: 20948443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.
    Jurk M; Chikh G; Schulte B; Kritzler A; Richardt-Pargmann D; Lampron C; Luu R; Krieg AM; Vicari AP; Vollmer J
    Nucleic Acid Ther; 2011 Jun; 21(3):201-14. PubMed ID: 21749297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7 and TLR3 Sense
    Campos PC; Gomes MT; Guimarães ES; Guimarães G; Oliveira SC
    Front Immunol; 2017; 8():28. PubMed ID: 28167945
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors.
    Sarvestani ST; Stunden HJ; Behlke MA; Forster SC; McCoy CE; Tate MD; Ferrand J; Lennox KA; Latz E; Williams BR; Gantier MP
    Nucleic Acids Res; 2015 Jan; 43(2):1177-88. PubMed ID: 25539920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-O-methyl-modified RNAs act as TLR7 antagonists.
    Robbins M; Judge A; Liang L; McClintock K; Yaworski E; MacLachlan I
    Mol Ther; 2007 Sep; 15(9):1663-9. PubMed ID: 17579574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of nucleic acid ligands by toll-like receptors 7/8: importance of chemical modification.
    Yu H; Wang Z; Sun G; Yu Y
    Curr Med Chem; 2012; 19(9):1365-77. PubMed ID: 22204348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses.
    Forsbach A; Nemorin JG; Montino C; Müller C; Samulowitz U; Vicari AP; Jurk M; Mutwiri GK; Krieg AM; Lipford GB; Vollmer J
    J Immunol; 2008 Mar; 180(6):3729-38. PubMed ID: 18322178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.
    Wilkinson A; Lattmann E; Roces CB; Pedersen GK; Christensen D; Perrie Y
    J Control Release; 2018 Dec; 291():1-10. PubMed ID: 30291987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7.
    Bourquin C; Schmidt L; Lanz AL; Storch B; Wurzenberger C; Anz D; Sandholzer N; Mocikat R; Berger M; Poeck H; Hartmann G; Hornung V; Endres S
    J Immunol; 2009 Nov; 183(10):6078-86. PubMed ID: 19890064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides.
    Diebold SS; Massacrier C; Akira S; Paturel C; Morel Y; Reis e Sousa C
    Eur J Immunol; 2006 Dec; 36(12):3256-67. PubMed ID: 17111347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids.
    Chen S; Zaifman J; Kulkarni JA; Zhigaltsev IV; Tam YK; Ciufolini MA; Tam YYC; Cullis PR
    J Control Release; 2018 Sep; 286():46-54. PubMed ID: 30026080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
    Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
    Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.